COMPANY PROFILE

Rx Redefined

Explore full profile

Medical logistics platform that allows physicians to extend services to patients who require specific medical products

Oakland, United StatesFounded 2017Health Tech & Medtech

Valuation $0–100M Latest valuation · 2023

Revenue $1–10M Latest reported FY

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Rx Redefined

Rx Redefined operates in the healthcare sector, providing a compliance-focused platform that enables physicians to manage the distribution of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) directly to their patients. The company primarily serves medical practices and their chronic patient populations, aiming to streamline the supply chain and improve patient outcomes. By integrating with medical distribution centers, Rx Redefined allows physicians to offer a wide range of brands, ensuring that patients receive the products they were trained on, thus eliminating unnecessary product switching and reducing delivery times.

Read full description

The business model revolves around two main products: Full Service and In Office. The Full Service product guides physicians through becoming licensed DMEPOS suppliers and helps them adhere to the 30 DMEPOS supplier standards. This service has shown a 23% decrease in utilization for commonly used urological prosthetics, indicating its effectiveness. The In Office product enables physicians to distribute medical supplies directly from their offices, further enhancing convenience for patients.

Rx Redefined generates revenue through subscription fees for its platform and additional services such as end-to-end revenue cycle management and routine audits. The company recently raised $8 million in Series A funding, highlighting investor confidence in its business model and growth potential.

Source: Dealroom company data